Skip to content
Market Spectator

Market Spectator

Primary Menu
  • Business
  • Domestic
  • Economy
  • Politics
  • Top News
  • Newsletters
Live
  • Home
  • 2024
  • September
  • 16
  • J&J gets $260 million talc verdict overturned in Oregon, new trial ordered

J&J gets $260 million talc verdict overturned in Oregon, new trial ordered

Market Spectator September 16, 2024
2024-09-16T173431Z_2_LYNXMPEK8F0NR_RTROPTP_4_JOHNSON-JOHNSON-TALC-LAWSUIT-7

By Brendan Pierson

(Reuters) – An Oregon judge has overturned a $260 million verdict against Johnson & Johnson in a lawsuit brought by a woman who said she got mesothelioma, a deadly cancer linked to asbestos exposure, from inhaling the company’s talc powder, the company said on Monday.

Judge Katharine von ter Stegge of the 4th Judicial District Circuit Court in Portland, Oregon, granted J&J’s motion to toss the verdict and hold a new trial in the case at a hearing late on Friday, according to a spokesperson for the company. Von ter Stegge is expected to issue an opinion explaining her order in the coming days.

Erik Haas, J&J’s worldwide vice president of litigation, said the original verdict was “the direct result of numerous egregious errors committed by the plaintiff’s lawyers” and had “no basis in the law or science.”

A lawyer for the Oregon woman, Kyung Lee, who sued the company along with her husband, did not immediately comment.

J&J is facing more than 62,000 plaintiffs’ claims that its baby powder and other talc products were contaminated with asbestos and caused cancer. Most of the lawsuits are over ovarian and other gynecological cancers, with a small minority over mesothelioma. J&J has said that its talc is safe, does not contain asbestos and does not cause cancer.

Lee was diagnosed with mesothelioma last year at age 48. She alleged that she inhaled asbestos-tainted talc over more than 30 years, beginning when her mother used it on her when she was a baby and later when she used it herself as a deodorant.

A lawyer for J&J said at trial that Lee’s illness was likely caused by exposure to asbestos used at a factory near where she grew up.

Friday’s decision comes as J&J is preparing to have a subsidiary file bankruptcy in order to settle the ovarian and other gynecological cancer lawsuits for about $9 billion. The company has said it has secured support for the deal from well over 75% of claimants, the legal threshold for a judge to approve the kind of bankruptcy settlement J&J has proposed.

The bankruptcy filing and settlement would not affect mesothelioma cases like Lee’s.

(Reporting By Brendan Pierson in New York; Editing by Alexia Garamfalvi and Leslie Adler)

About the Author

Market Spectator

Administrator

View All Posts

Post navigation

Previous: Fed rate cuts will not be as deep as the market expects, says BlackRock
Next: VR and AR headsets demand set to surge on AI, lower costs, IDC says

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Categories

  • Business
  • Domestic
  • Economy
  • Politics
  • Top News
  • Uncategorized

Recent Posts

  • European drinks group skid after US surgeon general calls for cancer warnings
  • AI a productivity boost to banks but making money from it is a challenge
  • Adobe forecasts fiscal 2025 revenue below estimates on slower subscription spending
  • Microsoft expects $800 million impairment charge in Q2 2025 over General Motors’ Cruise exit
  • Stunning rally in Big Tech drives Nasdaq to 20,000

You may have missed

2025-01-03T141432Z_1_LYNXMPEL020G8_RTROPTP_4_PERNOD-RICARD-INDIA-RAJASTHAN
  • Business

European drinks group skid after US surgeon general calls for cancer warnings

Market Spectator January 3, 2025
2024-12-11T214504Z_1_LYNXMPEKBA10D_RTROPTP_4_REUTERS-NEXT-GOLDMAN-SACHS-CEO
  • Business

AI a productivity boost to banks but making money from it is a challenge

Market Spectator December 11, 2024
2024-12-11T212535Z_1_LYNXMPEKBA102_RTROPTP_4_ADOBE-RESULTS
  • Business

Adobe forecasts fiscal 2025 revenue below estimates on slower subscription spending

Market Spectator December 11, 2024
2024-12-11T213952Z_1_LYNXMPEKBA109_RTROPTP_4_TECH-ANTIRUST-MICROSOFT
  • Business

Microsoft expects $800 million impairment charge in Q2 2025 over General Motors’ Cruise exit

Market Spectator December 11, 2024
  • Home
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Contact Us
Copyright 2025 © All rights reserved | Market Spectator | marketspectator.com